Adalimumab, etanercept or infliximab for RA?

26 September 2008 Print this article Comments Share this article
A new study compares three anti-tumour necrosis factor alpha agents in the first year of rheumatoid arthritis (RA), with recommendations on cost-effectiveness....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites